Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Evaluate the efficacy and safety of approved and emerging therapies based on current clinical trial data
- Select appropriate initial therapy using clinical evidence, guidelines, and patient- and disease-specific factors (including biomarkers)
Amer Zeidan, MD, MBBS
Professor of Internal Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale School of Medicine
Yale Cancer Center
Smilow Cancer Hospital
New Haven, CT
Prithviraj Bose, MD
Professor, Department of Leukemia
Co-Section Head, MPN Section
The University of Texas MD Anderson Cancer
Center
Houston, TX
Fadi Haddad, MD
Assistant Professor, Department of Leukemia
Co-Leader, Section of Chronic Myeloid
Leukemia
The University of Texas MD Anderson Cancer
Center
Houston, TX
Cristian Taborda, MD
Assistant Professor
Yale Cancer Center
Yale School of Medicine
New Haven, CT
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
